Phillip J Newton1, Patricia M Davidson2, Christopher M Reid3, Henry Krum4, Christopher Hayward5, David W Sibbritt6, Emily Banks7, Peter S MacDonald5. 1. Centre for Cardiovascular and Chronic Care, University of Technology Sydney, Sydney, NSW phillip.newton@uts.edu.au. 2. Centre for Cardiovascular and Chronic Care, University of Technology Sydney, Sydney, NSW. 3. Curtin University, Perth, WA. 4. Monash Centre of Cardiovascular Research and Education in Therapeutics, Monash University, Melbourne, VIC. 5. St Vincent's Hospital, Sydney, NSW. 6. Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Sydney, NSW. 7. National Centre for Epidemiology and Population Health, Australian National University, Canberra, ACT.
Abstract
OBJECTIVE: The primary aim of the NSW Heart Failure (HF) Snapshot was to obtain a representative cross-sectional view of patients with acute HF and their management in New South Wales and Australian Capital Territory hospitals. DESIGN AND SETTING: A prospective audit of consecutive patients admitted to 24 participating hospitals in NSW and the ACT with a diagnosis of acute HF was conducted from 8 July 2013 to 8 August 2013. RESULTS: A total of 811 participants were recruited (mean age, 77 ± 13 years; 58% were men; 42% had a left ventricular ejection fraction ≥ 50%). The median Charlson Comorbidity Index score was 3, with ischaemic heart disease (56%), renal disease (55%), diabetes (38%) and chronic lung disease (32%) the most frequent comorbidities; 71% of patients were assessed as frail. Intercurrent infection (22%), non-adherence to prescribed medication (5%) or to dietary or fluid restrictions (16%), and atrial fibrillation/flutter (15%) were the most commonly identified precipitants of HF. Initial treatment included intravenous diuretics (81%), oxygen therapy (87%), and bimodal positive airways pressure or continuous positive airways pressure ventilation (17%). During the index admission, 6% of patients died. The median length of stay in hospital was 6 days, but ranged between 3 and 12 days at different hospitals. Just over half the patients (59%) were referred to a multidisciplinary HF service. Discharge medications included angiotensin-converting enzyme inhibitors/angiotensin receptor blockers (59%), β-blockers (66%) and loop diuretics (88%). CONCLUSIONS: Patients admitted to hospital with acute HF in NSW and the ACT were generally elderly and frail, with multiple comorbidities. Evidence-based therapies were underused, and there was substantial interhospital variation in the length of stay. We anticipate that the results of the HF Snapshot will inform the development of strategies for improving the uptake of evidence-based therapies, and hence outcomes, for HF patients.
OBJECTIVE: The primary aim of the NSW Heart Failure (HF) Snapshot was to obtain a representative cross-sectional view of patients with acute HF and their management in New South Wales and Australian Capital Territory hospitals. DESIGN AND SETTING: A prospective audit of consecutive patients admitted to 24 participating hospitals in NSW and the ACT with a diagnosis of acute HF was conducted from 8 July 2013 to 8 August 2013. RESULTS: A total of 811 participants were recruited (mean age, 77 ± 13 years; 58% were men; 42% had a left ventricular ejection fraction ≥ 50%). The median Charlson Comorbidity Index score was 3, with ischaemic heart disease (56%), renal disease (55%), diabetes (38%) and chronic lung disease (32%) the most frequent comorbidities; 71% of patients were assessed as frail. Intercurrent infection (22%), non-adherence to prescribed medication (5%) or to dietary or fluid restrictions (16%), and atrial fibrillation/flutter (15%) were the most commonly identified precipitants of HF. Initial treatment included intravenous diuretics (81%), oxygen therapy (87%), and bimodal positive airways pressure or continuous positive airways pressure ventilation (17%). During the index admission, 6% of patients died. The median length of stay in hospital was 6 days, but ranged between 3 and 12 days at different hospitals. Just over half the patients (59%) were referred to a multidisciplinary HF service. Discharge medications included angiotensin-converting enzyme inhibitors/angiotensin receptor blockers (59%), β-blockers (66%) and loop diuretics (88%). CONCLUSIONS:Patients admitted to hospital with acute HF in NSW and the ACT were generally elderly and frail, with multiple comorbidities. Evidence-based therapies were underused, and there was substantial interhospital variation in the length of stay. We anticipate that the results of the HF Snapshot will inform the development of strategies for improving the uptake of evidence-based therapies, and hence outcomes, for HF patients.
Authors: Quin E Denfeld; Kerri Winters-Stone; James O Mudd; Jill M Gelow; Sawsan Kurdi; Christopher S Lee Journal: Int J Cardiol Date: 2017-02-10 Impact factor: 4.164
Authors: Xiaobo Yang; Josep Lupón; Maria T Vidán; Caleb Ferguson; Paloma Gastelurrutia; Phillip J Newton; Peter S Macdonald; Héctor Bueno; Antoni Bayés-Genís; Jean Woo; Erik Fung Journal: J Am Heart Assoc Date: 2018-12-04 Impact factor: 5.501
Authors: Gary Deed; John J Atherton; Michael d'Emden; Roy Rasalam; Anita Sharma; Andrew Sindone Journal: Diabetes Ther Date: 2019-07-10 Impact factor: 2.945
Authors: Daya Ram Parajuli; Sepehr Shakib; Joanne Eng-Frost; Ross A McKinnon; Gillian E Caughey; Dean Whitehead Journal: BMC Cardiovasc Disord Date: 2021-02-18 Impact factor: 2.298
Authors: Andrew P Sindone; Deepak Haikerwal; Ralph G Audehm; Alexander Munro Neville; Kevin Lim; Richard Whaddon Parsons; Peter Piazza; Danny Liew Journal: ESC Heart Fail Date: 2021-10-28
Authors: Mohammed S Al-Omary; Arshad A Khan; Allan J Davies; Peter J Fletcher; Dawn Mcivor; Bruce Bastian; Christopher Oldmeadow; Aaron L Sverdlov; John R Attia; Andrew J Boyle Journal: ESC Heart Fail Date: 2017-12-19
Authors: K Khoo; J Lew; P Neef; L Kearney; L Churilov; R Robbins; A Tan; M Hachem; L Owen-Jones; Q Lam; G K Hart; A Wilson; P Sumithran; D Johnson; P M Srivastava; O Farouque; L M Burrell; J D Zajac; E I Ekinci Journal: Sci Rep Date: 2018-09-10 Impact factor: 4.379